Palvella Therapeutics PVLA
NASDAQ PVLA
$167.95 -0.76 (-0.45%)
As of: Nov 11, 2026 · 11:22 AM EST

Palvella Therapeutics (PVLA) Long-Term Debt Issuances (2013 - 2024)

Updated

Palvella Therapeutics (PVLA) recorded Long-Term Debt Issuances of $6 million in Q4 2024, up 146.6% from the prior quarter.

Analysis

Palvella Therapeutics (PVLA) Long-Term Debt Issuances (2013 - 2024) Analysis & Trends

For FY2024, Palvella Therapeutics reported Long-Term Debt Issuances of $18.43 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Palvella Therapeutics 2.47 Bn 2.23 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 6.00 Mn
Sep 30, 2024 2.43 Mn
Mar 31, 2014 2,200.00
Dec 31, 2013 1,600.00
API Access

Palvella Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=PVLA&period=max&api_key=YOUR_API_KEY